Alginate (as a bone graft matrix)

Alginate is a linear polysaccharide built from two sugar acids, mannuronate and guluronate, extracted from the cell walls of brown algae such as Laminaria. Sodium alginate dissolves in water; when calcium or another divalent ion is added, guluronate blocks on neighbouring chains bind the ions between them and the solution sets into a gel. The gel forms at room temperature, without heat or chemical initiators, and its stiffness and persistence depend on the alginate’s composition, its concentration and the amount of calcium.

Lee and Mooney’s 2012 review and the 2020 and 2024 reviews of alginate in bone tissue engineering describe its use as a cell carrier, a scaffold and a bioink, and list its limitations: low mechanical strength, no intrinsic sites for cell attachment unless modified, and degradation by ion exchange rather than by enzymes, since mammals have no alginase.

In dentistry, “alginate” on its own almost always means impression material — a different product, mixed with water to set in the mouth and discarded after the impression. Alginate as a graft carrier has been studied in vitro and in animals but not, as far as a PubMed search on September 11, 2026 shows, in human bone grafting. One sheep study (Coathup et al., 2016) found that an alginate carrier reduced bone formation in a hydroxyapatite scaffold compared with bare granules; the state of evidence page treats that result as a design constraint.

On this site

The composition under development is a calcium-cross-linked alginate hydrogel carrying particulate graft. It contains no collagen, gelatin or other animal- or human-derived carrier. Nothing about its performance has been demonstrated; see how the composition is designed.